Posology : מינונים

4.2. POSOLOGY AND METHOD OF ADMINISTRATION
Note : Do not administer unless solution is clear and seal is intact

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution or container permit. Use of a final filter is recommended during administration of all parenteral solutions, where possible .

All injections in plastic containers are intended for intravenous administration using sterile equipment.
It is recommended that intravenous administration apparatus be replaced at least once every 24 hours.

Additives may be incompatible- see updated literature.
If additives are introduced to the solution use an aseptic technique and mix thoroughly.
Do not store solutions containing additives.
Dosage is depended upon the age, weight and clinical condition of the patient, as well as laboratory determinations.
Method of Administration:
The equipment should be primed with the solution to prevent air entering the system.
Do not connect flexible plastic containers in series in order to avoid air embolism due to possible residual air contained in the primary container.
Pressurizing intravenous solutions contained in flexible plastic containers to increase flow rates can result in air embolism if the residual air in the container is not fully evacuated prior to administration.
Use of a vented intravenous administration set with the vent in the open position could result in air embolism. Vented intravenous administration sets with the vent in the open position should not be used with flexible plastic containers.


Adding other medication or using an incorrect administration technique might cause the appearance of fever reactions due to the possible introduction of pyrogens. If an adverse event occurs the patient evaluated and appropriate countermeasures started. If needed the infusion should be stopped.
For information on incompatibilities and preparation of the product with additives, please see sections 6.2 and 6.6.